Barbara Davis Center for Diabetes

Running trials

• Recruiting

  Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

  NCT07864168· Source

• Recruiting

  Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems

  NCT07616206· Phase 2· Source

• Not yet recruiting

  PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study

  NCT07670650· Phase 3· Source

• Recruiting

  Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

  NCT07142252· Phase 2· Source

• Recruiting

  Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

  NCT06455319· Phase 2· Source

• Active, not recruiting

  Safety and Effectiveness of the Luna System in People With Type 1 Diabetes Mellitus

  NCT06627517· Source

• Recruiting

  A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

  NCT05762107· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Type 1 diabetes6 recruiting
• Type 2 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes

  NCT06719531· Source

• Completed

  ADJUnct Semaglutide Treatment in Type 1 Diabetes

  NCT05537233· Phase 2· Source

• Completed

  Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

  NCT05224258· Source